Topical Sevoflurane: A Novel Treatment for Chronic Pain Caused by Venous Stasis Ulcers

In the US, an estimated 1 - 2% of chronic venous insufficiency (CVI) patients (of 6 - 7 million nationwide) develop at least one venous stasis ulcer (VSU) during their illness. Of these, approximately 40% develop subsequent ulcers, making VSU prognostically poor. Current management of VSU is costly,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranke, Mayank, Pham, Cynthia T, Yilmaz, Melis, Wang, Jason K, Orhurhu, Vwaire, An, Daniel, Cornett, Elyse M., Kaye, Alan David, Ngo, Anh L, Imani, Farnad, Farahmand Rad, Reza, Varrassi, Giustino, Viswanath, Omar, Urits, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241821/
https://www.ncbi.nlm.nih.gov/pubmed/34221949
http://dx.doi.org/10.5812/aapm.112832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241821/
https://www.ncbi.nlm.nih.gov/pubmed/34221949
http://dx.doi.org/10.5812/aapm.112832

Ejemplares similares